Home › Funds › a16z Capital Management, L.L.C. › SYRE

a16z Capital Management, L.L.C. position in SYRE

SPYRE THERAPEUTICS INC · Health Care

a16z Capital Management, L.L.C. reported holding 3,082,725 shares of SYRE (SPYRE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$56.7M, representing 0.29% of its reported portfolio and ranking #6 among its reported holdings. a16z Capital Management, L.L.C. first reported this position in Q3 2026.

Latest position (Q3 2026)3.08M sh
Reported value held$56.74M
Portfolio Weight0.29%
First reportedQ3 2026
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How a16z Capital Management, L.L.C.'s SYRE position evolved

a16z Capital Management, L.L.C. first disclosed a stake in SYRE in Q3 2026 at 3,082,725 shares (US$56.7M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 3.08M $56.74M New

About SYRE and 13F data

SYRE (SPYRE THERAPEUTICS INC) is a Health Care company. 68 other funds we track also report a position in SYRE — the largest reported positions include Paradigm Biocapital Advisors LP (US$396.8M), RTW INVESTMENTS, LP (US$328.7M), PERCEPTIVE ADVISORS LLC (US$309.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SYRE

All SYRE fund holders →

FAQ

How long has a16z Capital Management, L.L.C. held SYRE?

a16z Capital Management, L.L.C. has disclosed SYRE holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is a16z Capital Management, L.L.C.'s current position in SYRE?

As of Q3 2026, a16z Capital Management, L.L.C. holds 3.08M shares of SYRE (SPYRE THERAPEUTICS INC), valued at $56.74M, representing 0.29% of its reported portfolio and ranking #6.

Has a16z Capital Management, L.L.C. been buying or selling SYRE?

In the latest 13F filing (Q3 2026), a16z Capital Management, L.L.C. newly opened its position in SYRE.

Which other funds hold SYRE?

Other major institutional holders of SYRE include Paradigm Biocapital Advisors LP, RTW INVESTMENTS, LP, PERCEPTIVE ADVISORS LLC, among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.